About 80 companies from the field of red biotechnology develop drugs, technology platforms and diagnostics at the Biotech Cluster Rhine-Neckar. Globally acting healthcare companies as well as internationally renowned research institutes also play a significant part in this development. With its focus on personalized medicine and cancer research the BioRN cluster occupies a leading position in Germany. In 2008 it was awarded the leading-edge cluster for “Cell based and molecular medicine in the Rhine-Neckar Metropolitan Region”. Researchers in academia and industry in the BioRN Cluster focus e.g. on therapeutics, diagnostics, bioinformatics, genomics, proteomics, biochip technology, peptide synthesis, tumor stem cell research or molecular modeling. BioRN Cluster Management is charged with the development and marketing of the cluster. The company offers access to the innovative potential of the cluster and is contact for those who are interested in the cluster or in its cluster members.